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ABSTRACT. Since national surveillance for acquired im-
munodeficiency syndrome (AIDS) began in 1981, the
Centers for Disease Control (CDC) has received reports
of more than 20,000 cases of AIDS in the United States.
As of December 31, 1985, 307 of these cases had been
diagnosed in children younger than 13 years of age. The
number of cases is increasing rapidly. The number of
cases reported in 1985 more than doubled those reported
in 1984. The major risk factors in children for acquiring
infection with the causative agent, human immunodefi-
ciency virus (HIV), were (1) having a mother known to
be infected and/or at increased risk for infection and (2)
receiving a transfusion of blood or blood products. Of the
307 children with AIDS, 73% were reported from one of
four states: New York, New Jersey, Florida, and Califor-
nia. Most AIDS cases in children occur in black or
Hispanic infants and toddlers. The estimated incubation
period for AIDS in children has increased each surveil-
lance year, with the longest incubation exceeding 7 years.
The prognosis for children with AIDS is poor and infants
less than 1 year of age have the shortest survival time
following diagnosis. Continued national surveillance for
AIDS is mandatory for establishing effective prevention
programs to control the spread of the disease. The CDC
encourages all health care personnel to report cases of
AIDS to their public health departments. Pediatrics
1987;79:1008-1014; acquired immunodeficiency syn-
drome, epidemiology, immunosuppression.
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CDC, Centers for Disease Control; HIV, human immunodefi-
ciency virus.
Received for publication Nov 12, 1986; accepted Jan 21, 1987.
Reprint requests to (M.F.R.) AIDS Program, Building 6, Room
282, Centers for Disease Control, Atlanta, GA 30333.
PEDIATRICS (ISSN 0031 4005). Copyright © 1987 by the
American Academy of Pediatrics.
Since national surveillance for acquired immu-
nodeficiency syndrome (AIDS) began in 1981, the
Centers for Disease Control (CDC) has received
reports of more than 20,000 AIDS cases in the
United States. By the end of 1985, 307 of these
cases had been diagnosed in children less than 13
years of age. Although they make up only 1% of the
total number of AIDS patients, they have unique
clinical, social, and public health problems that
require special attention. These include issues re-
lated to pregnancy, fetal health, day care, foster
care, school attendance, and immunizations.
Surveillance for AIDS in children has been an
important tool in monitoring its incidence and ep-
idemiology, in determining risk factors, and uncov-
ering new modes of transmission of the causal
agent, human immunodeficiency virus (HIV). In
this paper, we report our analysis of cases of pedi-
atric AIDS diagnosed through December 31, 1985,
reported to the CDC.
METHODS
The surveillance system is based on practicing
physicians and hospital personnel voluntarily re-
porting cases of pediatric AIDS to state or local
health departments. AIDS is an officially notifiable
disease in all 50 states, the District of Columbia,
and Puerto Rico. Between September 1982 and
September 1985, the CDC provided funding for
surveillance to health departments in 17 states, six
cities, and the territory of Puerto Rico. A standard
case report form is used to assure uniform data
collection.
The CDC case definition for AIDS in children is
similar to that used for adult patients, namely,
Protozoal and Helminthic Infections
Intestinal cryptosporidiosis causing chronic diarrhea
Pneumocystis carinii pneumonia
Strongyloides infection of the lungs, and CNS; dissemi-
nation infection
Disseminated toxoplasmosis infection of internal organs
other than liver, spleen, or lymph nodes
Isosporiasis causing chronic diarrhea*
Fungal Infections
Candida esophagitis
Bronchial or pulmonary candidiasis’
Disseminated cryptococcosis or meningitis
Disseminated histoplasmosis*
Bacterial Infections
Disseminated atypical mycobacterial infections
Viral Infections
Cytomegalovirus infection of internal organs other than
liver, spleen, or lymph nodes
Chronic mucocutaneous herpes simplex virus infection
or infection of the lungs or gastrointestinal tract be-
yond the mouth, throat, or rectum
Progressive multifocal leukoencephalopathy
Cancer
Kaposi sarcoma
Brain lymphoma
Non-Hodgkin lymphoma5
Idiopathic Disease
Chronic interstitial pneumonitist
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unexplained cellular immunodeficiency as mdi-
cated by the presence of an opportunistic infection,
Kaposi sarcoma, non-Hodgkins lymphoma, or pri-
mary lymphoma or the brain.1’2 The diseases that
the CDC considers indicative of cellular immuno-
deficiency are listed in Fig 1. Pediatric cases are
those occurring in children younger than 13 years
of age.
In the summer of 1985, the CDC revised the
original case definition for both children and adults
to include less specific diseases that occurred in
association with a positive test result for HIV in-
fection (Fig 1).2 For children, biopsy-proven chronic
lymphoid interstitial pneumonitis is considered in-
dicative of AIDS unless test results for HIV are
negative.
The definition also requires that diseases that
may mimic pediatric AIDS, such as congenital im-
mune disorders and congenital infections, must be
ruled out. Toxoplasmosis and congenital herpes
simplex infection must be diagnosed after 1 month
of age, and cytomegalovirus infection must be di-
agnosed after 6 months of age.
RESULTS
Temporal Trends
As in adults, the yearly incidence of AIDS in
children has increased since the occurrence of the
Fig 1. Diseases considered by the Centers for Disease
Control to be predictive of underlying cellular immuno-
deficiency associated with AIDS. *Must also have a pos-
itive test result for human immunodeficiency virus (HIV).
tUnless test results for HIV are negative.
earliest retrospectively diagnosed pediatric case in
1979. The first pediatric case was reported to the
CDC in November 1982, about 18 months after the
first case report in adults. The number of cases
reported in 1985 is 2.7 times the number of cases
reported in 1984 (Fig 2).
The time of transmission of the virus to children
in whom AIDS developed can be estimated by year
of birth for children who acquired the virus pen-
natally and by year of transfusion for those who
acquired the virus through blood transfusion (Fig
3). The earliest year of birth for children with
peninatally acquired AIDS is 1977. The earliest
transfusion of blood that is known to have infected
a child with HIV was given in 1978.
Risk Factors for Acquisition of HIV
Slightly more than three fourths of children with
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Fig 2. Pediatrics AIDS cases by date of report. Includes
children younger than 13 years of age in whom AIDS was
diagnosed as of Dec 31, 1985. **C definition changed
to include chronic lymphoid interstitial pneumonitis.
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Fig 3 Pediatrics AIDS cases by year of transmission of
human immunodeficiency virus. Includes children
younger than 13 years of age in whom AIDS was diag-
nosed as of Dec 31, 1985. Year of transmission was
considered year of birth for peninatally acquired cases
and year of transfusion for transfusion-acquired cases.
Pneumocystis carinii pneumonia was the most
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AIDS (n = 244) were born to mothers known to be
infected with HIV or at increased risk for infection
(Table 1). Of these 244 children, 74% (181) were
born to mothers who were IV drug users or the
sexual partners of IV drug users; 22% were born to
mothers who became infected through heterosexual
exposure to other infected men. For the latter
group, this assumes that Haitian mothers who deny
other risk factors such as IV drug abuse acquired
HIV infection through heterosexual transmission,
as studies among adults in this group have sug-
gested.
About one fifth of the children with AIDS had
received one or more transfusions of blood or blood
products (Table 1). The date of transfusion was
known for 40 of the 44 nonhemophiliac children;
all but two were transfused in the neonatal period.
At any given time, between 5% and 10% of pe-
diatnic cases cannot be classified in one of the
established risk groups (see “no identified risk”
category, Table 1), based on information in the
initial case report form. That is, the mode of acqui-
sition of HIV is unknown for these children. As
these cases are reported, they are investigated by
state and local health departments with the assist-
ance of the CDC to determine whether these cases
represent new modes of transmission of HIV. As
information becomes available from these investi-
gations, cases may be reclassified into the existing
risk groups. Those in whom no further information
can be obtained remain in the “no identified” risk
category. If new modes of transmission are discov-
ered through investigation of these cases, then new
risk groups are created. Since the initiation of sun-
veillance, 23 children were placed in the “no iden-
TABLE 1. Risk Factors Associated
AIDS Cases4
With Pediatric
Risk Factor No. (%)
of Cases
Perinatally acquired 244 (79)
Mother
IVdruguser 148 (48)
Haitian born 43 (14)
Partner of IV drug user 33 (11)
Partner of bisexual man 9 (3)
Partner of infected man, risk 1 (<1)
unknown
Partner of hemophiliac 1 (<1)
Received transfusion 1 (<1)
Infected, risk unknown 8 (3)
Transfusion acquired 44 (15)
Transfused in neonatal period 38 (11)
Transfused in childhood 2 (1)
Unknown data of transfusion 4 (1)
Hemophilia 12 (4)
No identified risk 7 (2)
4 Includes children younger than 13 years of age in whom
AIDS was diagnosed as of Dec 31, 1985.
tified” risk category when initially reported.
Through further investigation, 16 of these children
were found to belong to an existing risk group and
were reclassified; five children had died or their
parents were lost to follow-up, and no further in-
formation was available; and two cases are still
under investigation. The latter seven children re-
main in the “no identified” risk category (Table 1).
None of these “no identified” risk investigations by
the CDC and state and local health departments
have provided evidence that these children acquired
infection through casual contact in settings such as
school, family, or day care. Furthermore, none of
the reported pediatric AIDS cases were believed to
result from either sexual abuse or IV drug use
(either intentional or unintentional).
Geographic Distribution
The 307 pediatric cases reviewed here were re-
ported from 23 states, the District of Columbia, and
Puerto Rico; 73% of the cases were residents of one
of four states: New York, New Jersey, California,
and Florida (Fig 4). The proportion ofpatients with
pediatric AIDS residing in these four states de-
creased in 1985 as compared with earlier years
(Table 2). AIDS, particularly peninatally acquired
disease, is primarily a disease of urban children,
with 52% of the 307 patients residing in the stan-
dard metropolitan statistical areas of New York
City, Newark, NJ, and Miami (Table 3).
The geographic distribution of the peninatally
acquired cases differed from that of the transfusion-
acquired cases. Of the 244 perinatally acquired
cases, 75% were reported from New York, New
Jersey, and Florida compared with 30% of the 44
transfusion-acquired cases.
Opportunistic Diseases Associated With AIDS
Fig 4. Pediatric AIDS cases by state of child’s residence.
Includes children younget than 13 years of age in whom
AIDS was diagnosed as of Dec 31, 1985.
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TABLE 2. Reporting Trends for Pediatric AIDS
High and Low Prevalence Areas4
Year of Proportion of Children Total No.
Diagnosis With AIDS Residing in of Cases
Area (%)
High Low
Prevalence Prevalence
1979-1981 83 17 18
1982 78 22 23
1983 84 16 64
1984 78 22 78
1985 61 39 124
4 Data from children less than 13 years of age in whom
AIDS was diagnosed as of Dec 31, 1985. High prevalence
areas include New York, New Jersey, Florida, and Cali-
fornia; low prevalence areas include all other states.
TABLE 3. Incidence of Pediatric AIDS in Metropolitan
Areas4
New York Newark Miami
No. Incidence No. Incidence No. Incidence
5.7 1 3.8
2.8 3 11.5
14.2 8 30.7
14.2 5 19.2
22.7 11 42.2
59.6 28 107.5
1979-1981 7 4.5 2
1982 8 5.2 1
1983 32 20.7 5
1984 33 21.3 5
1985 31 20.0 8
Cumulative 111 71.7 21
4 Data from children younger than 13 years of age in
whom AIDS was diagnosed as of Dec 31, 1985. Incidence
is the number of cases per 1,000,000 children younger
than 13 years of age.
TABLE 4. Opportunistic Diseases and Malignancies
Reported for Children With AIDS4
Pneumocystis carinii pneumonia
Lymphoid interstitial pneumonitis
Disseminated cytomegalovirus
Candida esophagitis
Disseminated Mycobacterium avium
Cryptosporidiosis
Chronic herpes simplex virus
Kaposi sarcoma
Cryptococcosis
Toxoplasmosis
Progressive multifocal leukoencephal-
opathy
4 Includes children younger than 13 years of age in whom
AIDS was diagnosed as of Dec 31, 1985.
t Some children had more than one disease present.
common opportunistic disease in the pediatric pa-
tients, occurring in 53% (Table 4). Kaposi sarcoma,
a common malignancy in homosexual men with
AIDS, was reported in only 11 children. All 11 were
from the Miami area, and ten of the 1 1 cases were
in children born of Haitian parents. Of the 307
children, 45% has other opportunistic diseases, of
which lymphoid interstitial pneumonitis, Candida
in esophagitis, and disseminated cytomegalovirus in-
fection were the most common (Table 4). Fifty
percent of the children had two or more opportun-
istic infections.
Age Distribution
In the pediatric population, AIDS is primarily a
disease of infants and toddlers. Of the 307 cases,
80% (n = 246) were diagnosed in children younger
than 3 years of age (Fig 5). Only 28 of the 307
children were of school age (5 to 13 years). Another
85 cases (not reviewed here) were reported in ado-
lescents 13 to 19 years of age.
Estimated Incubation Period
Mean age at time of diagnosis of AIDS in children
with peninatally acquired infection can be used to
estimate the incubation period for AIDS. The mean
age of all such children was 17 months (range 1 to
86 months). However, the mean age has increased
over time (P = .043, linear regression analysis
[Table 5J).
The incubation period may also be estimated by
the time between transfusion of infected blood or
blood products and the time of diagnosis of trans-
fusion-acquired AIDS. Of the 40 transfusion-ac-
quired cases in children (excluding children with
hemophilia) with known dates of transfusion, the
mean time between transfusion and diagnosis was
24.4 months (range 4 to 82 months). This incuba-
tion period was significantly greater than that oh-
served for children with peninatally acquired AIDS
(P = .03, t test).
Racial Distribution
Ofthe 306 patients with pediatric AIDS of known
race, 178 (58%) were black, 71 (23%) were Hispanic,
and 57 (19%) were white. The racial/ethnic distni-
80
Age in Months Age in Years
Fig 5. Pediatric AIDS cases by child’s age at diagnosis.
Includes children younger than 13 years of age in whom
AIDS was diagnosed as of Dec 31, 1985.
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TABLE 5. Trends in Estimated Incubation Period for Children With Perinatally Acquired and Transfusion-Acquired
AIDS4
Year of
Diagnosis
Perinatally Acquired Transfusio n Acquired
No. of Mean Median Range No. of Mean Median Range
Children (mo) (mo) (mo) Children (mo) (mo) (mo)
1981 9 8.0 5.0 3-20
1982 14 17.3 14.0 3-44 4 15.3 12.0 10-27
1983 52 15.5 8.5 1-68 10 23.9 15.5 4-67
1984 66 16.8 9.0 1-79 9 23.3 15.0 8-68
1985 96 20.1 11.0 1-86 17 27.4 18.0 4-82
Cumulative 244 17.4 9.0 1-86 40 24.4 17.0 4-82
4 Incubation period estimated from age at time of diagnosis for children with perinatally acquired AIDS and interval
between transfusion and diagnosis for children with transfusion-acquired AIDS. Data from children less than 13 years
of age in whom AIDS was diagnosed as of Dec 31, 1985. Cumulative number of perinatally acquired cases includes
seven cases diagnosed prior to 1981 and cumulative number of transfusion-acquired cases excludes four cases for whom
the year of transfusion is unknown.
bution of children acquiring the virus from their
mothers differed from that of children acquiring
the virus from blood/blood product transfusion. Of
the 244 children with peninatally acquired AIDS,
91% were black or Hispanic, compared with 43% of
the 56 children with hemophilia or transfusion-
acquired AIDS.
Sex Distribution
Overall, the sex distribution in children slightly
favors boys, 53% compared with 47% girls. How-
ever, this distribution differs among risk groups. Of
the peninatally acquired cases, 48% compared with
68% of the transfusion-acquired cases (excluding
children with hemophilia) were in boys.
Prognosis
The proportion of children with AIDS who have
died is high, and the median survival is less than 1
year. Overall, 68% of the 307 children were known
to have died, and this proportion varied little among
the risk groups. The reported children with AIDS
survived a median of9.4 months following diagnosis
(standard error, 1.0 months), and 75% were dead
by 23.7 months (standard error, 3.14 months). Sur-
vival time was not statistically different when ana-
lyzed by risk group, sex, or race (generalized Wil-
coxon test [Breslow], generalized Savage test [Man-
tel-Cox]).
The proportion of deaths among infants (81%)
(younger than 1 year of age) was significantly
higher than the proportion of deaths among older
children (55%) (P < .001, x2 test). The median
survival time for infants (6.5 months, standard
error 0.6 months) was significantly less than for
older children (19.7 months, standard error 0.9
months) (P = .001, generalized Wilcoxon test; P =
.003, generalized Savage test [Fig 6]).
- 5 10 l 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90
Months of Survival Following Diagnosis
Fig 6. Survival time after diagnosis of AIDS in children
less than 13 years of age in whom AIDS was diagnosed
as ofDec 31, 1981, and reported to the Centers for Disease
Control.
DISCUSSION
The number of children with AIDS reported to
the CDC in 1985 has more than doubled the number
reported in 1984. Even if we exclude those with
only lymphoid interstitial pneumonitis to account
for changes in the case definition, the number of
cases reported in 1985 is 2.3 times that reported in
1984.
As the risk factors indicate, the two primary
modes of transmission in children are perinatal
exposure to infected mothers and transfusion of
blood/blood products. The use of donor-screening
programs5 and heat-treated coagulation products6
should virtually eliminate the latter form of trans-
mission. The mean incubation period for children
with transfusion-acquired AIDS is 24 months, and
no transfusion-acquired cases were reported in chil-
then receiving blood after institution of donor-
screening programs. However, a substantial num-
ber of children exposed to contaminated blood!
blood products before the prevention recommen-
dations remain at risk for AIDS.
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The most common mode of HIV transmission in
children is from infected mothers to their infants
during the perinatal period. Little is known about
peninatal transmission of HIV. Reports of AIDS in
children who had no further contact with their
mothers after birth7’8 and isolation of HIV from a
20-week fetus9 suggest that the virus can be trans-
mitted in utero and/or at birth through exposure to
infective maternal blood. One report of HIV infec-
tion in an infant who was breast-fed following a
postpartum transfusion of HIV-infected blood in
the mother’#{176} and another report of isolation of virus
from breast milk’1 suggest that transmission may
occur through breast-feeding. The frequency of
transmission from mothers to infants is unclear. It
has ranged from 0% in a small group of infants
born to mothers who were infected through artifi-
cial insemination12 to 65% in various other groups
who were studied.13’5
The geographic distribution of children with per-
inatally acquired AIDS parallels that of heterosex-
ual adults with AIDS, 72% of whom reside in pri-
manly urban areas of New York, New Jersey, and
Florida. IV drug abuse or sexual contact with an IV
drug user is reported by 69% of the heterosexual
adult patients with AIDS. The prevalence of anti-
body to HIV in populations of IV drug users varies
by geographic location with the highest rates in the
New York City/Newark, NJ, areas (50% to
7#{216}%)16.17 and lower rates in Boston 42%,18 San
Francisco 9%,17 and Chicago 11%.17 We can expect
to see the number of pediatric cases increasing in
other cities with large IV drug-using populations if
transmission is not prevented in this population.
The Public Health Service has published recom-
mendations for preventing peninatally acquired
HIV infection.’9 The recommendations stress that
counseling services and testing for antibody to HIV
should be offered to women at increased risk for
infection. Infected women should be encouraged to
postpone pregnancy until more is known about this
mode of transmission. Uninfected women should
be counseled to avoid infection. The Public Health
Service has also published recommendations to re-
duce IV drug abuse-related and sexual transmis-
sion.2#{176}
Based on the reported pediatric AIDS cases to
date, the estimated incubation period of AIDS var-
ies from 1 month to 7 years. The increase through-
out time in mean age at diagnosis of AIDS indicates
that the true mean incubation period may be longer
than the mean period observed during these early
years of the epidemic. A mathmatical model of
existing data for transfusion-acquired AIDS cases
in adults predicted that the mean incubation period
may be as long as 5 years.2’
The racial/ethnic distribution of pediatric AIDS
cases is related to the underlying risk factors for
acquisition of infection. The preponderance of
black and Hispanic children with perinatally ac-
quired AIDS reflects the racial/ethnic composition
of women at risk for HIV infection. Of the women
with AIDS, 87% are black or Hispanic. The pre-
ponderance of white race among children with he-
mophilia and transfusion-acquired AIDS probably
reflects the population of children receiving trans-
fusions. The cumulative incidence rate for black
children (27.4 cases per million population younger
than 13 years) and Hispanic children (14.3) is 16
and eight times, respectively, the rate for whites.
The 1:1 male to female ratio observed among
perinatally acquired cases indicates that boys and
girls are equally susceptible to the infection by this
route. However, a marked male preponderance was
seen in the transfusion-acquired cases. This re-
flects, in part, the sex distribution of the transfused
population of infants. Most (90%) of the children
with transfusion-acquired AIDS were infants trans-
fused in the neonatal period. A study of national
trends in transfusion practice22 found that more
male than female infants were transfused.
The prognosis for children with AIDS is poor;
the proportion of deaths is high and survival time
is short. The proportion of children reported here
who are known to have died is probably an under-
estimate, because follow-up of patients who were
alive at initial reporting varies from state to state,
and not all deaths are reported. Survival analysis
indicates that children in whom AIDS is diagnosed
when less than 1 year of age have a more fulminant
course compared with children in whom the diag-
nosis is made later in life. One study of 64 children
with AIDS reported to the New York City Depart-
ment of Health found that children with P carinii
pneumonia had a more fulminant course character-
ized by diagnosis at an earlier age (mean age at
diagnosis 11 months) than those with other oppor-
tunistic infections (mean age 31.4 months). In the
307 children reported to the CDC, those younger
than 1 year of age were more likely to have P carinii
pneumonia (72%) compared with older children
(38%) (P < .001, x2 test).
Because the CDC case definition requires the
presence of an opportunistic disease, these statistics
only reflect the more severe end of the spectrum of
HIV infection. In one recent report, 14 (48%) of 29
symptomatic HIV-infected children met the CDC
case definition for AIDS.24
Because of the long incubation period of pediatric
AIDS, cases reported at present represent trans-
mission that occurred a mean of 1 to 2 years ago.
By the time the first pediatric AIDS case had been
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reported in November 1982, 45% of the children in
whom the diagnosis was made by 1985 were already
infected. Monitoring seroprevalence rates in moth-
ens and children, particularly newborns, would give
communities a head start in controlling HIV infec-
tion.
The national surveillance system has successfully
monitored the occurrence of severe manifestations
of HIV infection. It has been valuable in determin-
ing new modes of transmission and the frequency
of different transmission routes and in assessing
epidemiologic trends. Surveillance is vital for public
health disease control and prevention. The CDC
strongly encourages all health personnel to report
AIDS cases to their local or state health depart-
ments.
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